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als according to the following criteria: (1) active and/or sham.  Focal  article
hao XF, Hu HT, Li JS, Shang HC, Zheng HZ, Niu JF, Shi
M,  Wang S. Is acupuncture effective for hypertension? A
ystematic review and meta-analysis. PLoS One. 2015 Jul
4;10(7):e0127019. doi:10.1371/journal.pone.0127019. eCollec-
ion 2015.
.  Aim
o review a meta-analysis of the effectiveness of acupuncture
n treating hypertension patients.
.  Data  sourceshe authors searched for relevant articles in the following
atabases: PUBMED, EMBASE, Cochrane Central Register of
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http://creativecommons.org/licenses/by-nc-nd/4.0/).controlled trials, International Clinical Trials Register Platform
of the World Health Organization (WHO), Chinese Scientiﬁc
Journal Database, China National Knowledge Infrastructure
(CNKI), and the Chinese Evidence-Based Medicine Database.1
Articles had publication dates between the inception of the
databases and April 2014.
4.  Study  selection
The authors only included randomized controlled trials
(RCTs). The criteria for hypertension in the focal review were:
systolic blood pressure (SBP) ≥ 140 mmHg  and/or diastolic
BP (DBP) ≥ 90 mmHg. Furthermore, the authors selected tri- Hee University Korean Medicine Hospital, 23 Kyungheedae-ro,
control procedure used; and (2) primary outcome measure-
ment of absolute BP before and after intervention, difference
between BP values before and after treatment, or efﬁcacy rate.
vier. This is an open access article under the CC BY-NC-ND license
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Clinical trials that used acupressure, laser acupuncture, tran-
scutaneous electrical nerve stimulation, or herbal medicine as
a control intervention were excluded. Ultimately, 23 studies
were included in the review.
5.  Data  extraction
Data were collected regarding the participants themselves,
acupuncture treatment, control groups, course of treatment,
treatment sessions, and primary and secondary outcomes
(i.e., SBP or DBP after intervention, SBP or DBP differences after
treatment, efﬁcacy rate, and adverse events).1
6.  Intervention
The acupuncture group included patients who had been
treated using (electro-) acupuncture, both as monotherapy or
in combination with Western medicine. The control group
consisted of patients treated using sham acupuncture, West-
ern medicine, or lifestyle modiﬁcation and Western medicine
combined with sham acupuncture.
7.  Main  outcome  measurements
The main outcome measurements were: SBP after interven-
tion, DBP after intervention, SBP change, DBP change, and
efﬁcacy rate.
8.  Main  results
1) Absolute BP after intervention: neither SBP nor DBP were
signiﬁcantly different after treatment (11 trials).
2) Change in BP after intervention:
A. Acupuncture versus sham acupuncture: acupuncture
did not differ from sham acupuncture in terms of SBP
change after intervention; but the change in DBP was
signiﬁcant [2 trials, 216 patients; DBP mean difference
(MD) = –1.40, 95% conﬁdence interval (CI) = –2.37 to –0.44,
I2 = 8%].
B. Acupuncture combined with Western medication
versus Sham acupuncture combined with Western
medication: acupuncture combined with Western med-
ication was more  beneﬁcial than sham acupuncture
combined with Western medication (2 trials, 170
patients; SBP MD  = –7.47, 95% CI = -10.43 to –4.51, I2 =
0%; DBP MD  = –4.22, 95% CI = –6.26 to –2.18, I2 = 0%).
3) Efﬁcacy rate: acupuncture did not differ from Western
medicine in terms of efﬁcacy rate (10 trials). However,
acupuncture combined with Western medication had a
greater efﬁcacy rate than Western medication alone [4 tri-
als, 230 patients; odds ratio (OR) = 4.19, 95% CI = 1.65 to
210.67, I = 0%].
4) Safety: only four trials reported adverse events. Spot bleed-
ing, hypertensive urgency, and congestive heart failure
were reported. Pain was reported as a minor adverse event.Integr Med Res (  2 0 1 6 ) 69–71
9.  Authors’  conclusions
Both SBP change and DBP change were greater when acupunc-
ture was combined with Western medication than when sham
acupuncture was combined with Western medication. Fur-
thermore, acupuncture combined with Western medication
had a greater efﬁcacy rate. This implies that acupuncture has
an additive effect when combined with medication to treat
hypertension. However, there is not enough evidence to con-
ﬁrm that acupuncture alone has an effect.
10.  Comment/critique
Several systematic reviews (SRs) have addressed the use of
acupuncture to treat hypertension; each had its own lim-
itations. Some reviews did not include all relevant trials
conducted in China only included trials published before
2010.2,3 Li et al4 published an SR in 2014 that contained
only four RCTs. Another SR, written in 2013 by Wang et al5,
included trials that were not rigorous RCTs. To overcome
such limitations, the authors of the focal review broadened
the search by removing language restrictions, adding recently
published trials, and including only methodologically rigor-
ous RCTs in their review. Nonetheless, several limitations
remained; for instance, most trials included had been con-
ducted in China—trials which usually report positive results,
perhaps as a result of bias.1
Substantial heterogeneity among studies, as well as a high
risk of bias due to poor description of methods calls into ques-
tion the results of this meta-analysis.1 In addition, several
studies used an efﬁcacy rate that, although common in Chi-
nese clinical trials, is not an internationally accepted standard
in the ﬁeld of hypertension. Efﬁcacy rate is deﬁned as the pro-
portion of patients who reach a target blood pressure, set in
advance. Interestingly, acupuncture combined with Western
medicine had a greater efﬁcacy rate than Western medicine
alone, while the two did not differ in terms of either SBP or
DBP. This controversial result implies that efﬁcacy rate is not
a rational and powerful outcome, and that we  should therefore
be cautious when interpreting the results of this review.1
In the focal review, there were several implications for
future studies. Firstly, blood pressure should be evaluated
using a 24-hour ambulatory blood pressure monitoring (ABPM)
device. It is known that a decrease in SBP of 10 mmHg, or in
DBP of 5 mmHg, reduces the risk of strokes by 41%, and of
coronary heart disease by 22%.6 Furthermore, even a small
change in SBP (2–4 mmHg) is clinically relevant; for this rea-
son, the authors recommend precise BP measurement.1 In the
focal review, only three trials used an ABPM device. A recently
published trial by Li et al7, which was not included in this
SR, did use an ABPM device; the trial showed a signiﬁcant BP
reduction in the acupuncture group. Li et al8 reported a pro-
tocol for acupuncture to treat mild hypertension; they also
used an ABPM device, because ABPM is better than clinical BP
measurement in predicting cardiovascular events. Speciﬁcally,
in a 5-year follow-up study, ABPM predicted cardiovascular
risk even after adjustment for the clinical BP measurement.
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herefore, the adoption of 24-hour ABPM in cases of hyper-
ension is desirable.
Another implication for the future was that the duration,
ose, and frequency of acupuncture treatment are important.
n the focal review, treatment duration ranged from 7 days to
6 days, and the number of treatment sessions from ﬁve to
5. In a previous investigation, 5 days of acupuncture treat-
ent did not reduce BP.9 Conversely, a pilot trial by Liu et al10
hat addressed acupuncture for mild hypertension showed
 reduction in DBP of 5.7 mmHg  after 4 weeks of treatment
hich was not included in the focal review. On the basis of
revious research,11 as well as the pilot trial result, Liu et al10
uggested a treatment duration of more  than 4 weeks, with a
requency of more  than twice/wk.
The focal review also made it clear that the location of
he acupoints is important. The most frequently selected
cupoints among the hypertension clinical trials were LR3
taichong, 12 trials), LI11 (quchi, 11 trials), GB20 (fengchi, 10
rials), and ST36 (zusanli, 8 trials); these were followed in fre-
uency by LI4 (hegu, 5 trials), SP6 (sanyinjiao, 5 trials), CV4
guanyuan, 5 trials), and PC6 (neiguan, 4 trials).1 It is known
hat increased activity in the renin–angiotensin–aldosterone
ystem (RAAS), as well as in the sympathetic nervous system
SNS), causes hypertension.12 In a preliminary study, acupunc-
ure reduced elevated renin, aldosterone, and norepinephrine
evels, implying lowered activity in both the RAAS and the
NS.7 In some clinical trials, the results of treatment using
cupoint combinations such as PC5-6 or ST36-37 have been
etter than those of treatment using LI6-7 or GB37-39; this
mplies that acupoint speciﬁcity is important.7,12 According
o a review by Longhurst13, the use of acupoints located on
eep somatic nerves (such as PC5-6, ST36-37, LI4-7, and LI10-
1) evoked greater activity in the rostral ventrolateral medulla,
nd reduced BP more,  than the use of acupoints located on
uperﬁcial nerves. The authors of the focal review stated that
ham acupuncture may not be a proper placebo control1; for
his reason, selecting appropriate acupoint combinations on
he basis of several previous mechanistic and clinical studies
s essential in both the treatment and control groups.
Other controversies, such as those of manual acupunc-
ure versus electroacupuncture and low frequency versus
igh frequency electroacupuncture stimulation, are under
nvestigation.13 Small sample size of included RCTs is also
 challenge of acupuncture research. By referring to issues
aised in this SR and commentary, future researchers may
mprove the methodological quality of acupuncture research
n the ﬁeld of hypertension; this should lead to more reliable
esults.71
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